TXG News and Press, 10x Genomics Inc. From 07/14/22

ARK Invest’s 13F portfolio value decreased from $23.96B to $16.91B this quarter. Coinbase Global, Roku, Shopify, and Ginkgo Bioworks were increased while decreasing Spotify, Ionis Pharma, Vertex Pharma, and Sea Limited. The top three positions are Tesla, Zoom Video, and Rok...

10x Genomics ( NASDAQ: TXG ) said that it expects Q2 2022 revenue to be ~$114.5M , below the consensus estimate of $127.67M. That's a 1% decrease from the year-ago period. Shares are down 13% in after-hours trading. While year-over-year revenue increased in...

10x Genomics Names Jim Wilbur as Chief Commercial Officer PR Newswire PLEASANTON, Calif. , July 14, 2022 /PRNewswire/ -- Following a comprehensive search process, 10x Genomics, Inc. (Nasdaq: TXG), today announced the hiring of Jim Wilbur , Ph.D., as C...

10x Genomics Announces Preliminary Second Quarter 2022 Revenue PR Newswire PLEASANTON, Calif. , July 14, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced th...

Baillie Gifford’s 13F portfolio value decreased from ~$182B to ~$143B this quarter. They increased Affirm Holdings, Coupang, and Ginkgo Bioworks while reducing Petroleo Brasileiro and First Republic Bank. The top three positions are Tesla Motors, Moderna, and Illumina, and ...

China is cutting its quarantine time for international travelers to 10 days, which is lending support to sectors like casino stocks. Morgan Stanley just published its Global Exposure Guide, which tracks revenue and cost exposure by region. "While China is a very important source of revenue fo...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Recent declines on Wall Street have been unnerving for most investors. So far in the year the S&P 500 index has lost around 21%. But you can still find some interesting stocks to buy right now. Investing is a long-t...

10x Genomics Advances Leadership and Innovation in Single Cell and Spatial Technologies at 2022 AGBT General Meeting PR Newswire Demonstrates first-ever commercial product capable of single-cell RNA sequencing on FFPE tissues Opens preorders for CytAssist, th...

2022 has been brutal for early-stage biotech companies. Cathie Wood's Ark Genomic Revolution ETF is down 60% over the past year. Wood's long-term performance is outstanding, however, even after that huge drop. Some of her stocks have gotten a lot cheaper in the short term. But the poten...

Biotech is one of the fastest growing areas in healthcare, and one of the more exciting sectors in the stock market. Here's why three Fool.com contributors are bullish on 10x Genomics (NASDAQ: TXG) , Axsome Therapeutics (NASDAQ: AXSM) , and Doximity (NYSE: DOCS) ...